Sage Therapeutics Announces Second Quarter 2020 Financial Results and Highlights Pipeline and Business Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to Sage Therapeutics Announces Second Quarter 2020 Financial Results and Highlights Pipeline and Business Progress

SAGE Therapeutics (SAGE) Tops Q2 EPS by 3c

August 10, 2020 6:32 AM EDT

SAGE Therapeutics (NASDAQ: SAGE) reported Q2 EPS of ($2.63), $0.03 better than the analyst estimate of ($2.66). Revenue for the quarter came in at $1.09 million versus the consensus estimate of $890 thousand.

We have created a novel drug company successfully able to convert our chemical equity... More